WIPO trademark

RESNIBEN

MixedWIPOClass 5

"RESNIBEN" is a trademark owned by Azurity Pharmaceuticals, Inc., filed at the WIPO on October 30, 2025. It is on file and covers class 5 (Pharmaceuticals).

RESNIBEN
Trademark as filed with the WIPO
Status
Mixed
Filed
October 30, 2025
Registered
Not yet
Expires
October 30, 2035
Application no.
Not recorded
Registration no.
1906172
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
1 class
Ownership

Who owns RESNIBEN

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Azurity Pharmaceuticals, Inc.

32 trademarks in the portfolioView company

Representative

Gowling WLG (Canada) LLP

Gowling WLG (Canada) LLP

Goods and services

What the mark covers

The products and services RESNIBEN is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of cancer, pain, infection, inflammation, hormone disorders, bone disorders, and mental disorders; analgesics; hormones for medical purposes; psychotropics; anti-infectives; anti-inflammatories; anti-cancer preparations.

FAQ

About RESNIBEN

Who owns the trademark "RESNIBEN"?

The WIPO trademark "RESNIBEN" is owned by Azurity Pharmaceuticals, Inc.

What is the status of "RESNIBEN"?

Its status at the WIPO is: mixed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RESNIBEN and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_d6403871-2faa-49f3-89d0-b009d82ecf04
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_d6403871-2faa-49f3-89d0-b009d82ecf04",
  "object": "trademark",
  "mark_text": "RESNIBEN",
  "status": {
    "primary": "mixed",
    "stage": "mixed"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2025-10-30",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Azurity Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb725-e6a7-73db-81c8-7bbc8473b1bf"
    }
  ]
}